Main competitors
1m. Revenue rev. 4m. EPS revision 4m. Revenue rev. 1y. EPS revision 1y. Revenue rev. Visibility Nbr of analysts
27
22
28
18
21
22
24
29
27
26
24
23
22
20
15
15
15
18
Average 22
Weighted average by Cap. 24
Other Pharmaceuticals